NMD4C and Muscular Dystrophy Canada (MDC) are pleased to invite you to a webinar on the current state of spinal muscular atrophy (SMA) in Canada.

This webinar is primarily targeted at Canadian clinicians and clinical academics with an interest in SMA. The speakers will discuss current SMA issues both generally and in the context of COVID-19. It will be similar to previous SMA summits, but in a short webinar format. NMD4C and MDC are providing organisational and technical support, and this is an independent clinical/academic webinar with no industry participation or sponsorship.

Read the webinar report HERE

Topics and speakers:

SMA Clinical Care in the Era of COVID-19

Dr. Jodi Warman Chardon (NMD4C Steering Committee member)

Newborn Screening in Ontario

Dr. Kristin Kernohan, Dr. Alex Mackenzie, Dr. Hugh McMillan (NMD4C Investigator)

Update on Zolgensma for Canada

Dr. Hugh McMillan (NMD4C Investigator)

Update on Risdiplam for Canada

Dr. Craig Campbell (NMD4C Investigator)

Adult Outcome Measures

Dr. Colleen O’Connell

Update on CNDR-SMA Project

Dr. Lawrence Korngut (NMD4C Investigator), Dr. Victoria Hodgkinson (NMD4C Collaborator)